155 results
Page 5 of 8
20-F/A
EX-4.38
yhaogg4cuow0ge8bp7bj
23 Mar 15
Annual report (foreign) (amended)
12:00am
424B5
zbsfalpvhqexrj84w4
6 Mar 15
Prospectus supplement for primary offering
12:00am
424B5
11g72cbv68byts
5 Mar 15
Prospectus supplement for primary offering
12:00am
6-K
EX-99.3
1gsy1
5 Mar 15
Current report (foreign)
12:00am
6-K
EX-99
g5o1 i14fax
12 Dec 14
BioLineRx Presents Multi-Year Clinical Development
12:00am
6-K
EX-99
fs6p4mc0detknm3ric
8 Dec 14
BioLineRx Reports Positive Data from Ongoing Phase 2a
12:00am
6-K
EX-99
icxgdv6g8
10 Nov 14
BioLineRx Reports Third Quarter 2014 Financial Results
12:00am
6-K
EX-99
qnm5tauk868356pf
6 Aug 14
BioLineRx Reports Second Quarter 2014 Financial Results
12:00am
424B2
xiyd3hw vh2gy4o
13 Jun 14
Prospectus for primary offering
12:00am
6-K
EX-1.1
873m lltnlw2lx720d
30 May 14
Current report (foreign)
12:00am
F-3
0x7d8lak
30 May 14
Shelf registration (foreign)
12:00am
6-K
EX-99
mp7mmk6 mgfxh6d0b66
20 May 14
BioLineRx Reports First Quarter 2014 Financial Results
12:00am
6-K
EX-1.1
wg6zm1swd
7 Mar 14
BioLineRx Closes $24.1 Million Underwritten Public Offering
12:00am
424B5
34lho9m3w88qwd44w
4 Mar 14
Prospectus supplement for primary offering
12:00am
424B5
w52uu8u1
3 Mar 14
Prospectus supplement for primary offering
12:00am
6-K
EX-99.3
eufq3lydrdc9k u50kn
3 Mar 14
Current report (foreign)
12:00am
424B3
73d8tdz
8 Aug 13
Prospectus supplement
12:00am